Inducible and transmissible genetic events and pediatric tumors of the nervous system

Journal of Radiation Research

Volumn 47, Issue SUPPL. B, 2006, Pages

  Rice, Jerry M ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brain tumors; Gene environment interactions; Genetically engineered mice; Transplacental carcinogenesis; Tumor suppressor genes

Indexed keywords

BRAIN; DISEASES; GENES; GENETIC ENGINEERING; IONIZING RADIATION; MAMMALS; PEDIATRICS; TUMORS;

BRAIN TUMORS; CARCINOGENESES; CLINICAL MANIFESTATION; GENE-ENVIRONMENT INTERACTION; GENETICALLY ENGINEERED MOUSE; NEUROFIBROMATOSIS; RETINOBLASTOMA; SPORADICS; TRANSPLACENTAL CARCINOGENESIS; TUMOUR SUPPRESSOR GENES;

PATHOLOGY;

MAMMALIA; RODENTIA;

EID: 33749556391     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.47.B1     Document Type: Article

References (61)

1. nd Edition, Eds. D. Schottenfeld and J. F. Fraumeni, Jr., pp. 1331-1369 Oxford University, Press, New York.
2. Kleihues, P., Cavenee, W. K., Eds. (2000) Pathology and Genetics of Tumours of the Nervous System, World Health Organization Classification of Tumours, International Agency for Research on Cancer, Lyon.
3. Tomatis, L., Mohr, U., Eds. (1973) Transplacental Carcinogenesis, IARC Scientific Publications No. 4, International Agency for Research on Cancer, Lyon.
4. Rice, J. M., Ed. (1979) Perinatal Carcinogenesis. NCI Monograph No. 51, National Cancer Institute, U. S. Government Printing Office, Washington, DC.
5. Napalkov, N. P., Rice, J. M., Tomatis, L., Yamasaki, H., Eds. (1989) Perinatal and Multigeneration Carcinogenesis. IARC Scientific Publications No. 96. International Agency for Research on Cancer, Lyon.
6. Rice, J. M. (2004) Causation of nervous system tumors in children: insights from traditional and genetically engineered animal models. Toxicol. Appl. Pharmacol. 199: 175-191.
7. Rice, J. M., Wilbourn, J. D. (2000) Tumors of the nervous system in carcinogenic hazard identification. Toxicol. Pathol. 28: 202-214.
8. IARC (2003) Predictive value of Rodent Forestomach and Gastric Neuroendocrine Tumours in Evaluating Carcinogenic Risks to Humans. International Agency for Research on Cancer, Lyon.
9. Druckrey, H., Ivankovic, S., Preussmann, R. (1966) Teratogenic and carcinogenic effects in the offspring after single injection of ethylnitrosourea to pregnant rats. Nature 210: 1378-1379.
10. Rice, J. M. (1973) An overview of transplacental chemical carcinogenesis. Teratology 8: 113-126.
11. Rice, J. M. (1979) Perinatal period and pregnancy: intervals of high risk for chemical carcinogens. Environ. Health Perspect. 29: 23-27.
12. Rice, J. M. (1981) Effects of prenatal exposure to chemical carcinogens and methods for their detection. In Developmental Toxicology, Eds. C. A. Kimmel and J. Buelke-Sam, Chapter 11, pp191-212 Raven Press, New York.
13. Anderson, L. M., Diwan, B. A., Fear, N. T., Roman, E. (2000) Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models. Environ. Health Perspect. 108, Suppl. 3: 573-594.
14. Rice, J. M., Ward, J. M. (1988) Schwannomas (induced), cranial, spinal, and peripheral nerves, rat. In ILSI Monographs on Pathology of Laboratory Animals. Nervous System, Eds. T. C. Jones, U. Mohr and R. D. Hunt, pp154-160 Springer-Verlag, Berlin, Heidelberg.
15. Ivankovic, S., Druckrey, H. (1968) Transplacental induction of malignant tumors of the nervous system. I. Ethylnitrosourea in BD-IX rats [in German]. Z. Krebsforsch. 71: 320-360.
16. Rice, J. M., Rehm, S., Donovan, P. J., Perantoni, A. O. (1989) Comparative transplacental carcinogenesis by directly acting and metabolism dependent alkylating agents in rodents and nonhuman primates. In Perinatal and Multigeneration Carcinogenesis, Eds. N. P. Napalkov, J. M. Rice, L. Tomatis and H. Yamasaki, IARC Scientific Publications No. 96, pp17-34 International Agency for Research on Cancer, Lyon.
17. Druckrey, H., Schagen, B., Ivankovic, S. (1970) Induction of neurogenic malignancies by single administration of ethylnitrosourea (ENU) to newborn and young BD IX rats [in German]. Z. Krebsforsch. 74: 141-161.
18. Perantoni, A. O., Rice, J. M., Reed, C. D., Watatani, M., Wenk, M. L. (1987) Activated neu oncogene sequences in primary tumors of the peripheral nervous system induced in rats by transplacental exposure to ethylnitrosourea. Proc. Natl. Acad. Sci. USA 84: 6317-6321.
19. Buzard, G. S., Enomoto, T., Hongyo, T., Perantoni, A. P., Diwan, B. A., Devor, D. E., Reed, C. D., Dove, L. F., Rice, J. M. (1999) neu Mutation in schwannomas induced transplacentally in Syrian golden hamsters by N-nitrosoethylurea: high incidence but low allelic representation. J. Cancer Res. Clin. Oncol. 125: 529-540.
20. Buzard, G. S., Enomoto, T., Anderson, L. M., Perantoni, A. O., Devor, D. E., Rice, J. M. (1999) Activation of neu by missense point mutation in the transmembrane domain in schwannomas induced in C3H/HeNCr mice by transplacental exposure to N-nitrosoethylurea. J. Cancer Res. Clin. Oncol. 125: 653-659.
21. Perantoni, A. O., Rice, J. M. (1999) Mutation patterns in non-ras oncogenes and tumour suppressor genes in experimentally induced tumours. In The Use of Short- and Medium-term Tests for Carcinogens and Data on Genetic Effects in Carcinogenic Hazard Evaluation, IARC Scientific Publications No. 146, Eds. D. B. McGregor, J. M. Rice and S. Venitt, pp88-122 International Agency for Research on Cancer, Lyon.
22. Dibb, N. J., Dilworth, S. M., Mol, C. D. (2004) Switching on kinases: oncogenic activation of BRAF and the PDGFR family. Nat. Rev. Cancer 4: 718-727.
23. Shigematsu, H., Takahashi, T., Nomura, M., Majmudar, K., Suzuki, M., Lee, H., Wistuba, I. I., Fong, K. M., Toyooka, S., Shimizu, N., Fujisawa, T., Minna, J. D., Gazdar, A. F. (2005) Somatic mutations of the HER2 kinase domain in lung adenocarcinoma. Cancer Res. 65: 1642-1646.
24. Brustle, O., Ohgaki, H., Schmitt, H. P., Walter, G. F., Ostertag, H., Kleihues, P. (1992) Primitive neuroectodermal tumors after prophylactic central nervous system irradiation in children. Association with an activated K-ras gene. Cancer 69: 2385-2392.
25. Cavenee, W. K., Furnari, F. B., Nagane, M., Huang, H. J. S., Newcomb, E. W., Bigner, D. D., Weller, M., Berens, M. E., Plate, K. H., Israel, M. A., Noble, M. D., Kleihues, P. (2000) Diffusely infiltrating astrocytomas. In Pathology and Genetics of Tumours of the Nervous System, Eds. P. Kleihues and W. K. Cavenee, pp 10-21 IARC Press, International Agency for Research on Cancer, Lyon.
26. Neglia, J. P., Meadows, A. T., Robison, L. L., Kim, T. H., Newton, W. A., Ruymann, F. B., Sather, H. N., Hammond, J. D. (1991) Second neoplasms after acute lymphoblastic leukemia in childhood. New Engl. J. Med. 325: 1330-1336.
27. Ron, E., Modan, B., Boice, J. D. Jr, Alfandary, E., Stovall, M., Chetrit, A., Katz, L. (1988) Tumors of the brain and nervous system after radiotherapy in childhood. N. Engl. J. Med. 319: 1033-1039.
28. Kleinschmidt, D., Lillehei, K. O. (1995) Radiation-induced meningioma with a 63 year latency period. Case report. J. Neurosurg. 82: 487-488.
29. Harrison, M. J., Wolfe, D. E., Lau, T. S., Mitnick, R. J., Sachdev, D. P. (1991) Radiation-induced meningiomas: experience at the Mount Sinai Hospital and review of the literature. J. Neurosurg. 75: 564-574.
30. Boffetta, P., Tredaniel, J., Greco, A. (2000) Risk of childhood cancer and adult lung cancer after childhood exposure to passive smoke: A meta-analysis. Environ. Health Perspect. 108: 73-82.
31. Wong, F. L., Boice, J. D. Jr., Abramson, D. H., Tarone, R. E., Kleinerman, R. A., Stovall, M., Goldman, M. B., Seddon, J. M., Tarbell, N., Fraumeni, J. F. Jr., Li, F. P. (1997) Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. J. Am. Med. Assoc. 278: 1262-1267.
32. Knudson, A. G. (1971) Mutation and cancer: Statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 68: 820-823.
33. Knudson, A. G., Hethcote, H. W., Brown, B. W. (1975) Mutation and childhood cancer: A probabilistic model for the incidence of retinoblastoma. Proc. Natl. Acad. Sci. USA 72: 5116-5120.
34. Smith, B. J., O'Brien, J. M. (1996) The genetics of retinoblastoma and current diagnostic testing. J. Pediatr. Ophthalmol. Strabismus 33: 120-123.
35. Louis, D. N., Scheithauer, B. W., Budka, H., von Deimling, A., Kepes, J. J. (2000) Meningiomas. In Pathology and Genetics of Tumours of the Nervous System, Eds. P. Kleihues and W. K. Cavenee, pp176-184 IARC Press, Lyon.
36. Louis, D. N., Stemmer-Rachamimov, A. O., Wiestler, O. D. (2000) Neurofibromatosis type II. In Pathology and Genetics of Tumours of the Nervous System, Eds. P. Kleihues and W. K. Cavenee, pp219-222 IARC Press, Lyon.
37. Tohma, Y., Gratas, C., Biernat, W., Peraud, A., Fukuda, M., Yonekawa, Y., Kleihues, P. and Ohgaki, H. (1998) PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J. Neuropathol. Exptl. Neurol. 57: 684-689.
38. Kleihues, P., Davis, R. L., Ohgaki, H., Burges, P. C., Westphal, M. M., Cavenee, W. K. (2000) Diffuse astrocytoma. In Pathology and Genetics of Tumours of the Nervous System, Eds. P. Kleihues and W. K. Cavenee, pp22-26 IARC Press, Lyon.
39. Wolter, M., Reifenberger, J., Sommer, C., Ruzicka, T., Reifenberger, G. (1997) Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res. 57: 2581-2585.
40. Huang, H., Mahler-Araujo, B. M., Sankila, A., Chimelli, L., Yonekawa, Y., Kleihues, P., Ohgaki, H. (2000) APC mutations in sporadic medulloblastomas. Am. J. Pathol. 156: 433-437.
41. Ohgaki, H., Vital, A., Kleihues, P., Hainaut, P. (2000) Li-Fraumeni syndrome and TP53 germline mutations. In Pathology and Genetics of Tumours of the Nervous System, Eds. P. Kleihues and W. K. Cavenee, pp231-234 IARC Press, Lyon.
42. von Deimling, A., Foster, R., Krone, W. (2000) Neurofibromatosis type I. In Pathology and Genetics of Tumours of the Nervous System, Eds. P. Kleihues and W. K. Cavenee, pp 216-218 IARC Press, Lyon.
43. Reifenberger, G., Wiestler, O. D., Chenevix-Trench, G. (2000) Naevoid basal cell carcinoma syndrome. In Pathology and Genetics of Tumours of the Nervous System, Eds. P. Kleihues and W. K. Cavenee, pp240-241 IARC Press, Lyon.
44. Cavenee, W. K., Burger, P. C., van Meier, E. G. (2000) Turcot syndrome. In Pathology and Genetics of Tumours of the Nervous System, Eds. P. Kleihues and W. K. Cavenee, pp238-239 IARC Press, Lyon.
45. Wiestler, O. D., Lopes, B. S., Green, A. J., Vinters, H. V. (2000) Tuberous sclerosis complex and subependymal giant cell astrocytoma. In Pathology and Genetics of Tumours of the Nervous System, Eds. P. Kleihues and W. K. Cavenee, pp227-230 IARC Press, Lyon.
46. Wiestler, O. D., Padberg, G. W., Steck, P. A. (2000) Cowden disease and dysplastic gangliocytoma of the cerebellum/Lhermitte-Duclos disease. In Pathology and Genetics of Tumours of the Nervous System, Eds. P. Kleihues and W. K. Cavenee, pp235-237 IARC Press, Lyon.
47. Weiss, W. A., Israel, M., Cobbs, C., Holland, E., James, C. D., Louis, D. N., Marks, C., McClatchey, A. I., Roberts, T., Van Dyke, T., Wetmore, C., Chiu, I. M., Giovannini, M., Guha, A., Higgins, R. J., Marino, S., Radovanovic, I., Reilly, K., Aldape, K. (2002) Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum. Oncogene 21: 7453-7463.
48. Marigo, V., Laufer, E., Nelson, C. E., Riddle, R. D., Johnson, R. L., Tabin, C. (1996) Sonic hedgehog regulates patterning in early embryos. Biochem. Soc. Symp. 62: 51-60.
49. Stone, D. M., Hynes, M., Armanini, M., Swanson, T. A., Gu, Q., Johnson, R. L., Scott, M. P., Pennica, D., Goddard, A., Phillips, H., Noll, M., Hooper, J. E., de Sauvage, F., Rosenthal, A. (1996) The tumour-suppressor gene patched encodes a candidate receptor for Sonic hedgehog. Nature 384: 129-134.
50. Wetmore, C., Eberhart, D. E., Curran, T. (2001) Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched. Cancer Res. 61: 513-516.
51. Marino, S., Vooijs, M., van Der Gulden, H., Jonkers, J., Berns, A. (2000) Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev. 14: 994-1004.
52. Tong, W. M., Ohgaki, H., Huang, H., Granier, C., Kleihues, P., Wang, Z. Q. (2003) Null mutation of DNA strand break-binding molecule poly(ADP-ribose) polymerase causes meduloblastomas in p53(-/-) mice. Am. J. Pathol. 162: 343-352.
53. Reilly, K. M., Loisel, D. A., Bronson, R. T., McLaughlin, M. E., Jacks, T. (2000) Nf1; Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects. Nat. Genet. 26: 109-113.
54. Cichowski, K., Shih, T. S., Schmitt, E., Santiago, S., Reilly, K., McLaughlin, M. E., Bronson, R. T., Jacks, T. (1999) Mouse models of tumor development in neurofibromatosis type 1. Science 286: 2172-2176.
55. Pazzaglia, S., Mancuso, M., Atkinson, M. J., Tanori, M., Rebessi, S., Majo, V. D., Covelli, V., Hahn, H., Saran, A. (2002) High incidence of medulloblastoma following X-ray-irradiation of newborn Ptc1 heterozygous mice. Oncogene 21: 7580-7584.
56. Oda, H., Zhang, S., Tsurutani, N., Shimizu, S., Nakatsuru, Y., Aizawa, S., Ishikawa, T. (1997) Loss of p53 is an early event in induction of brain tumors in mice by transplacental carcinogen exposure. Cancer Res. 57: 646-650.
57. Wechsler, W., Rice, J. M., Vesselinovitch, S. D. (1979) Transplacental and neonatal induction of neurogenic tumors in mice: Comparison with related species and with human pediatric neoplasms. Natl. Cancer Inst. Monogr. 51: 219-226.
58. Zakut-Houri, R., Oren, M., Bienz, B., Lavie, V., Hazum, S., Givol, D. (1983) A single gene and a pseudogene for the cellular tumour antigen p53. Nature 306: 594-597.
59. Weghorst, C. M., Buzard, G. S., Calvert, R. J., Hulla, J. E., Rice, J. M. (1995) Cloning and sequence of a processed p53 pseudogene from rat: a potential source of false 'mutations' in PCR fragments of tumor DNA. Gene 166: 317-322.
60. Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., Weinberg, R. A. (1992) Effects of an Rb mutation in the mouse. Nature 359: 295-300.
61. Lee, E. Y., Chang, C. Y., Hu, N., Wang, Y. C., Lai, C. C., Herrup, K., Lee, W. H., Bradley, A. (1992) Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359: 288-294.